Press Releases

Date	Title	PDF Version
Oct 12, 2009	Alexion Pharmaceuticals to Report Third Quarter 2009 Results on October 22, 2009
Sep 16, 2009	Alexion to Present at the UBS Global Life Sciences Conference
Sep 08, 2009	Alexion to Present at Investor Conferences
Aug 06, 2009	European Commission and U.S. FDA Grant Alexion's Soliris® (eculizumab) Orphan Drug Designation for the Treatment of Atypical Hemolytic Uremic Syndrome (aHUS)
Jul 23, 2009	Alexion Reports Second Quarter 2009 Results
Jul 09, 2009	Alexion Pharmaceuticals to Report Second Quarter 2009 Results on July 23, 2009
Jun 19, 2009	Alexion Extends Its Commitment to a Green Footprint Through Its Ambitious New Solar Energy System
Jun 10, 2009	Alexion to Present at the Jefferies & Co. 3rd Annual Healthcare Conference
Jun 10, 2009	Alexion's Soliris(R) Receives 2009 Prix Galien France for Most Innovative Drug for Rare Disease
Jun 07, 2009	New Research Presented at EHA Congress Shows That Soliris(R) Significantly Reduced Hemolysis in Never-Transfused Patients with PNH

Search